213 related articles for article (PubMed ID: 20407894)
21. Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients.
Markovic S; Drozina G; Vovk M; Fidler-Jenko M
Hepatogastroenterology; 1999; 46(29):2925-30. PubMed ID: 10576374
[TBL] [Abstract][Full Text] [Related]
22. Systemic corticosteroid and reactivation of chronic hepatitis B.
Lai CL; Yuen MF
Respirology; 2010 Oct; 15(7):1017-8. PubMed ID: 20874743
[No Abstract] [Full Text] [Related]
23. Lamivudine for chemotherapy-induced reactivation of HBV: prophylaxis or treatment?
Mancuso A; Pagliaro L
Am J Gastroenterol; 2002 May; 97(5):1268-9. PubMed ID: 12014746
[No Abstract] [Full Text] [Related]
24. [Therapy-related Virus Reactivation in Lymphoma Patients with Hepatitis B Virus Infection--Review].
Li Z; Li ZJ; Xi YM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):266-70. PubMed ID: 26913434
[TBL] [Abstract][Full Text] [Related]
25. [Hepatitis B reactivation with rituximab in an HIV-infected anti-HBs antibody carrier].
Benghalia K; Roussin-Bretagne S; Marque-Juillet S; Colardelle P; Chochon M; Harzic M; Doll J
Med Mal Infect; 2011 Aug; 41(8):437-9. PubMed ID: 21700407
[No Abstract] [Full Text] [Related]
26. Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma.
Tsutsumi Y; Tanaka J; Kawamura T; Miura T; Kanamori H; Obara S; Asaka M; Imamura M; Masauzi N
Ann Hematol; 2004 Jan; 83(1):58-60. PubMed ID: 14513286
[TBL] [Abstract][Full Text] [Related]
27. Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.
Dai MS; Chao TY; Kao WY; Shyu RY; Liu TM
Ann Hematol; 2004 Dec; 83(12):769-74. PubMed ID: 15338194
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus reactivation in a patient with resolved hepatitis B virus infection receiving maintenance rituximab for malignant B-cell lymphoma.
Koo YX; Tan DS; Tan IB; Tao M; Lim ST
Ann Intern Med; 2009 May; 150(9):655-6. PubMed ID: 19414854
[No Abstract] [Full Text] [Related]
29. Hepatitis B virus reactivation and role of antiviral prophylaxis in lymphoma patients with past hepatitis B virus infection who are receiving chemoimmunotherapy.
Koo YX; Tan DS; Tan IB; Tao M; Chow WC; Lim ST
Cancer; 2010 Jan; 116(1):115-21. PubMed ID: 19899164
[TBL] [Abstract][Full Text] [Related]
30. [Impending liver failure after chemoimmunotherapy-induced reactivation of hepatitis B - successful treatment with entecavir].
Lock G; Helmich F; Bertram M
Dtsch Med Wochenschr; 2012 Jun; 137(23):1248-50. PubMed ID: 22644491
[TBL] [Abstract][Full Text] [Related]
31. A drug safety evaluation of rituximab and risk of hepatitis B.
Riedell P; Carson KR
Expert Opin Drug Saf; 2014 Jul; 13(7):977-87. PubMed ID: 24821316
[TBL] [Abstract][Full Text] [Related]
32. [Reactivation of hepatitis B virus in patients treated with systemic chemotherapy].
Kusumoto S
Nihon Rinsho; 2015 Feb; 73 Suppl 2():375-9. PubMed ID: 25831786
[No Abstract] [Full Text] [Related]
33. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
Yeo W; Chan TC; Leung NW; Lam WY; Mo FK; Chu MT; Chan HL; Hui EP; Lei KI; Mok TS; Chan PK
J Clin Oncol; 2009 Feb; 27(4):605-11. PubMed ID: 19075267
[TBL] [Abstract][Full Text] [Related]
34. [Hepatitis B virus reactivation after cessation of prophylactic lamivudine therapy in B-cell lymphoma patients treated with rituximab combined CHOP therapy].
Mimura N; Tsujimura H; Ise M; Sakai C; Kojima H; Fukai K; Yokosuka O; Takagi T; Kumagai K
Rinsho Ketsueki; 2009 Dec; 50(12):1715-9. PubMed ID: 20068280
[TBL] [Abstract][Full Text] [Related]
35. Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients.
Pei SN; Chen CH; Lee CM; Wang MC; Ma MC; Hu TH; Kuo CY
Ann Hematol; 2010 Mar; 89(3):255-62. PubMed ID: 19697028
[TBL] [Abstract][Full Text] [Related]
36. Reactivation of resolved hepatitis B during rituximab therapy for rheumatoid arthritis.
Ghrénassia E; Mékinian A; Rouaghe S; Ganne N; Fain O
Joint Bone Spine; 2012 Jan; 79(1):100-1. PubMed ID: 21944979
[No Abstract] [Full Text] [Related]
37. Hepatitis B reactivation and rituximab: a new boxed warning and considerations for solid organ transplantation.
Martin ST; Cardwell SM; Nailor MD; Gabardi S
Am J Transplant; 2014 Apr; 14(4):788-96. PubMed ID: 24592928
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.
Steinberg JL; Yeo W; Zhong S; Chan JY; Tam JS; Chan PK; Leung NW; Johnson PJ
J Med Virol; 2000 Mar; 60(3):249-55. PubMed ID: 10630955
[TBL] [Abstract][Full Text] [Related]
39. Fulminant hepatitis B following rituximab therapy in a patient with Evans syndrome and large B-cell lymphoma.
Ozgönenel B; Moonka D; Savaşan S
Am J Hematol; 2006 Apr; 81(4):302. PubMed ID: 16550511
[No Abstract] [Full Text] [Related]
40. Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.
Yeo W; Johnson PJ
Hepatology; 2006 Feb; 43(2):209-20. PubMed ID: 16440366
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
